Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Stemcell Holdings Cash from Operations (Quarterly): 0.8509M for Sept. 30, 2018
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 0.8509M |
| June 30, 2018 | -0.0988M |
| March 31, 2018 | 1.100M |
| December 31, 2017 | 0.6922M |
| September 30, 2017 | -0.3555M |
| June 30, 2017 | 2.238M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.052M |
| December 31, 2016 | 1.654M |
| September 30, 2016 | 1.456M |
| June 30, 2016 | 0.214M |
| March 31, 2016 | 0.0425M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 4.188M |
| Electromed Inc | 1.351M |
| Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.1868M |